{"entity":{"type":"insider","cik":"0001709772","url":"/insider/0001709772","json_url":"/insider/0001709772.json","name":"Bergstrom Donald A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":62,"n_filings":52,"first":"2021-04-20","last":"2026-07-30","span_basis":"filed_date"},"name_variants":[{"name":"Bergstrom Donald A","source":"filing","n_filings":52,"first_seen":"2021-04-20","last_seen":"2026-07-30"}],"transactions":[{"id":5944500,"accession":"0001193125-26-326137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-326137","line_url":"/filing/0001193125-26-326137#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2237.0,"shares_display":"2,237","price_per_share":18.61,"price_display":"18.61","price_state":"stated","total_value":41630.57,"total_display":"41,630.57","shares_owned_after":407660.0,"shares_owned_after_display":"407,660","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-28","filed_date":"2026-07-30","scope":"insider"},{"id":5751579,"accession":"0001193125-26-298688","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-298688","line_url":"/filing/0001193125-26-298688#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8660.0,"shares_display":"8,660","price_per_share":18.71,"price_display":"18.71","price_state":"stated","total_value":162028.6,"total_display":"162,028.60","shares_owned_after":409897.0,"shares_owned_after_display":"409,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-08","scope":"insider"},{"id":6006128,"accession":"0001193125-26-281059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-281059","line_url":"/filing/0001193125-26-281059#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93456.0,"shares_display":"93,456","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":1583144.64,"total_display":"1,583,144.64","shares_owned_after":418557.0,"shares_owned_after_display":"418,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider"},{"id":5785158,"accession":"0001193125-26-197395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-197395","line_url":"/filing/0001193125-26-197395#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1490.0,"shares_display":"1,490","price_per_share":14.79,"price_display":"14.79","price_state":"stated","total_value":22037.1,"total_display":"22,037.10","shares_owned_after":418557.0,"shares_owned_after_display":"418,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":6133580,"accession":"0001193125-26-029415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-029415","line_url":"/filing/0001193125-26-029415#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2686.0,"shares_display":"2,686","price_per_share":8.45,"price_display":"8.45","price_state":"stated","total_value":22696.7,"total_display":"22,696.70","shares_owned_after":420047.0,"shares_owned_after_display":"420,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-28","filed_date":"2026-01-29","scope":"insider"},{"id":6133576,"accession":"0001193125-26-029415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-029415","line_url":"/filing/0001193125-26-029415#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18895.0,"shares_display":"18,895","price_per_share":7.62,"price_display":"7.62","price_state":"stated","total_value":143979.9,"total_display":"143,979.90","shares_owned_after":422733.0,"shares_owned_after_display":"422,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-27","filed_date":"2026-01-29","scope":"insider"},{"id":5069490,"accession":"0001193125-25-258557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-258557","line_url":"/filing/0001193125-25-258557#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30897.0,"shares_display":"30,897","price_per_share":7.29,"price_display":"7.29","price_state":"stated","total_value":225239.13,"total_display":"225,239.13","shares_owned_after":521823.0,"shares_owned_after_display":"521,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-28","filed_date":"2025-10-30","scope":"insider"},{"id":4912532,"accession":"0000950170-25-100365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-100365","line_url":"/filing/0000950170-25-100365#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26701.0,"shares_display":"26,701","price_per_share":3.68,"price_display":"3.68","price_state":"stated","total_value":98259.68,"total_display":"98,259.68","shares_owned_after":552720.0,"shares_owned_after_display":"552,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-30","scope":"insider"},{"id":4912527,"accession":"0000950170-25-100365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-100365","line_url":"/filing/0000950170-25-100365#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4069.0,"shares_display":"4,069","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":15218.06,"total_display":"15,218.06","shares_owned_after":579421.0,"shares_owned_after_display":"579,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-07-30","scope":"insider"},{"id":4235562,"accession":"0000950170-25-061365","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-061365","line_url":"/filing/0000950170-25-061365#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27472.0,"shares_display":"27,472","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":82416.0,"total_display":"82,416.00","shares_owned_after":583490.0,"shares_owned_after_display":"583,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-30","filed_date":"2025-04-30","scope":"insider"},{"id":4235556,"accession":"0000950170-25-061365","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-061365","line_url":"/filing/0000950170-25-061365#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4090.0,"shares_display":"4,090","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":12965.3,"total_display":"12,965.30","shares_owned_after":610962.0,"shares_owned_after_display":"610,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-28","filed_date":"2025-04-30","scope":"insider"},{"id":4526056,"accession":"0000950170-25-047762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-047762","line_url":"/filing/0000950170-25-047762#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":986.0,"shares_display":"986","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":2800.24,"total_display":"2,800.24","shares_owned_after":615052.0,"shares_owned_after_display":"615,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-27","filed_date":"2025-03-31","scope":"insider"},{"id":4099030,"accession":"0000950170-25-011319","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-25-011319","line_url":"/filing/0000950170-25-011319#line-4","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30823.0,"shares_display":"30,823","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":136237.66,"total_display":"136,237.66","shares_owned_after":616038.0,"shares_owned_after_display":"616,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-30","scope":"insider"},{"id":4099026,"accession":"0000950170-25-011319","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-011319","line_url":"/filing/0000950170-25-011319#line-3","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46407.0,"shares_display":"46,407","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":211151.85,"total_display":"211,151.85","shares_owned_after":646861.0,"shares_owned_after_display":"646,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":4099023,"accession":"0000950170-25-011319","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-011319","line_url":"/filing/0000950170-25-011319#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3220.0,"shares_display":"3,220","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":14908.6,"total_display":"14,908.60","shares_owned_after":516868.0,"shares_owned_after_display":"516,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-28","filed_date":"2025-01-30","scope":"insider"},{"id":2958582,"accession":"0000950170-24-141598","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-141598","line_url":"/filing/0000950170-24-141598#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":657.0,"shares_display":"657","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":2877.66,"total_display":"2,877.66","shares_owned_after":520088.0,"shares_owned_after_display":"520,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2024-12-31","scope":"insider"},{"id":2242813,"accession":"0000950170-24-118981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-118981","line_url":"/filing/0000950170-24-118981#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2688.0,"shares_display":"2,688","price_per_share":6.06,"price_display":"6.06","price_state":"stated","total_value":16289.28,"total_display":"16,289.28","shares_owned_after":520745.0,"shares_owned_after_display":"520,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-28","filed_date":"2024-10-30","scope":"insider"},{"id":2418798,"accession":"0000950170-24-110808","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-110808","line_url":"/filing/0000950170-24-110808#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":648.0,"shares_display":"648","price_per_share":7.51,"price_display":"7.51","price_state":"stated","total_value":4866.48,"total_display":"4,866.48","shares_owned_after":523433.0,"shares_owned_after_display":"523,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-10-01","scope":"insider"},{"id":2142421,"accession":"0000950170-24-088812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-088812","line_url":"/filing/0000950170-24-088812#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2698.0,"shares_display":"2,698","price_per_share":8.85,"price_display":"8.85","price_state":"stated","total_value":23877.3,"total_display":"23,877.30","shares_owned_after":524081.0,"shares_owned_after_display":"524,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-29","filed_date":"2024-07-31","scope":"insider"},{"id":2344008,"accession":"0000950170-24-079692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-079692","line_url":"/filing/0000950170-24-079692#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":648.0,"shares_display":"648","price_per_share":6.26,"price_display":"6.26","price_state":"stated","total_value":4056.48,"total_display":"4,056.48","shares_owned_after":526779.0,"shares_owned_after_display":"526,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-27","filed_date":"2024-07-01","scope":"insider"},{"id":2037231,"accession":"0000950170-24-050146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-050146","line_url":"/filing/0000950170-24-050146#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2686.0,"shares_display":"2,686","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":17136.68,"total_display":"17,136.68","shares_owned_after":527427.0,"shares_owned_after_display":"527,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-29","filed_date":"2024-04-29","scope":"insider"},{"id":2141390,"accession":"0000950170-24-038656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-038656","line_url":"/filing/0000950170-24-038656#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":765.0,"shares_display":"765","price_per_share":7.7,"price_display":"7.70","price_state":"stated","total_value":5890.5,"total_display":"5,890.50","shares_owned_after":530113.0,"shares_owned_after_display":"530,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-29","scope":"insider"},{"id":2248109,"accession":"0001209191-24-002470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-002470","line_url":"/filing/0001209191-24-002470#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3178.0,"shares_display":"3,178","price_per_share":9.64,"price_display":"9.64","price_state":"stated","total_value":30635.92,"total_display":"30,635.92","shares_owned_after":530878.0,"shares_owned_after_display":"530,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":8024019,"accession":"0001209191-23-059996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059996","line_url":"/filing/0001209191-23-059996#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":977.0,"shares_display":"977","price_per_share":11.51,"price_display":"11.51","price_state":"stated","total_value":11245.27,"total_display":"11,245.27","shares_owned_after":234056.0,"shares_owned_after_display":"234,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-27","filed_date":"2023-12-29","scope":"insider"},{"id":8156039,"accession":"0001209191-23-054020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-054020","line_url":"/filing/0001209191-23-054020#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3451.0,"shares_display":"3,451","price_per_share":6.03,"price_display":"6.03","price_state":"stated","total_value":20809.53,"total_display":"20,809.53","shares_owned_after":235033.0,"shares_owned_after_display":"235,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-30","filed_date":"2023-11-01","scope":"insider"},{"id":8116888,"accession":"0001209191-23-050869","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-050869","line_url":"/filing/0001209191-23-050869#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":648.0,"shares_display":"648","price_per_share":8.38,"price_display":"8.38","price_state":"stated","total_value":5430.24,"total_display":"5,430.24","shares_owned_after":238484.0,"shares_owned_after_display":"238,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-27","filed_date":"2023-09-29","scope":"insider"},{"id":8470052,"accession":"0001209191-23-043838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-043838","line_url":"/filing/0001209191-23-043838#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2683.0,"shares_display":"2,683","price_per_share":11.8,"price_display":"11.80","price_state":"stated","total_value":31659.4,"total_display":"31,659.40","shares_owned_after":237904.0,"shares_owned_after_display":"237,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-28","filed_date":"2023-07-31","scope":"insider"},{"id":8022872,"accession":"0001209191-23-040059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-040059","line_url":"/filing/0001209191-23-040059#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":647.0,"shares_display":"647","price_per_share":12.12,"price_display":"12.12","price_state":"stated","total_value":7841.64,"total_display":"7,841.64","shares_owned_after":240587.0,"shares_owned_after_display":"240,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-28","scope":"insider"},{"id":9271996,"accession":"0001209191-23-033416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033416","line_url":"/filing/0001209191-23-033416#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2850.0,"shares_display":"2,850","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":31806.0,"total_display":"31,806.00","shares_owned_after":241234.0,"shares_owned_after_display":"241,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-06-01","scope":"insider"},{"id":8438141,"accession":"0001209191-23-026275","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-026275","line_url":"/filing/0001209191-23-026275#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1383.0,"shares_display":"1,383","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":15434.28,"total_display":"15,434.28","shares_owned_after":242701.0,"shares_owned_after_display":"242,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-05-01","scope":"insider"},{"id":8606784,"accession":"0001209191-23-021417","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021417","line_url":"/filing/0001209191-23-021417#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":763.0,"shares_display":"763","price_per_share":15.36,"price_display":"15.36","price_state":"stated","total_value":11719.68,"total_display":"11,719.68","shares_owned_after":244084.0,"shares_owned_after_display":"244,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-28","scope":"insider"},{"id":8151206,"accession":"0001209191-23-005696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005696","line_url":"/filing/0001209191-23-005696#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1429.0,"shares_display":"1,429","price_per_share":21.56,"price_display":"21.56","price_state":"stated","total_value":30809.24,"total_display":"30,809.24","shares_owned_after":244847.0,"shares_owned_after_display":"244,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-01-31","scope":"insider"},{"id":6306833,"accession":"0001209191-22-062818","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062818","line_url":"/filing/0001209191-22-062818#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":14.49,"price_display":"14.49","price_state":"stated","total_value":14200.2,"total_display":"14,200.20","shares_owned_after":85886.0,"shares_owned_after_display":"85,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-28","scope":"insider"},{"id":6730325,"accession":"0001209191-22-055116","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-055116","line_url":"/filing/0001209191-22-055116#line-3","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":22.75,"price_display":"22.75","price_state":"stated","total_value":182000.0,"total_display":"182,000.00","shares_owned_after":86866.0,"shares_owned_after_display":"86,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-01","scope":"insider"},{"id":6730319,"accession":"0001209191-22-055116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055116","line_url":"/filing/0001209191-22-055116#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1817.0,"shares_display":"1,817","price_per_share":21.54,"price_display":"21.54","price_state":"stated","total_value":39138.18,"total_display":"39,138.18","shares_owned_after":86866.0,"shares_owned_after_display":"86,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-11-01","scope":"insider"},{"id":6787451,"accession":"0001209191-22-052221","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-052221","line_url":"/filing/0001209191-22-052221#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":22.43,"price_display":"22.43","price_state":"stated","total_value":179440.0,"total_display":"179,440.00","shares_owned_after":88683.0,"shares_owned_after_display":"88,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider"},{"id":6457401,"accession":"0001209191-22-051542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051542","line_url":"/filing/0001209191-22-051542#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":976.0,"shares_display":"976","price_per_share":22.73,"price_display":"22.73","price_state":"stated","total_value":22184.48,"total_display":"22,184.48","shares_owned_after":88683.0,"shares_owned_after_display":"88,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-29","scope":"insider"},{"id":6252639,"accession":"0001209191-22-049242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-049242","line_url":"/filing/0001209191-22-049242#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","shares_owned_after":89659.0,"shares_owned_after_display":"89,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-08","scope":"insider"},{"id":6353279,"accession":"0001209191-22-048561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048561","line_url":"/filing/0001209191-22-048561#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4900.0,"shares_display":"4,900","price_per_share":25.46,"price_display":"25.46","price_state":"stated","total_value":124754.0,"total_display":"124,754.00","shares_owned_after":89659.0,"shares_owned_after_display":"89,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-02","scope":"insider"},{"id":6893588,"accession":"0001209191-22-048391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-048391","line_url":"/filing/0001209191-22-048391#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8100.0,"shares_display":"8,100","price_per_share":23.07,"price_display":"23.07","price_state":"stated","total_value":186867.0,"total_display":"186,867.00","shares_owned_after":89659.0,"shares_owned_after_display":"89,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-01","scope":"insider"},{"id":6893507,"accession":"0001209191-22-047560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-047560","line_url":"/filing/0001209191-22-047560#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","shares_owned_after":89659.0,"shares_owned_after_display":"89,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-25","scope":"insider"},{"id":6574045,"accession":"0001209191-22-044859","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-044859","line_url":"/filing/0001209191-22-044859#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","shares_owned_after":89659.0,"shares_owned_after_display":"89,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-08","scope":"insider"},{"id":6305185,"accession":"0001209191-22-043536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-043536","line_url":"/filing/0001209191-22-043536#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1835.0,"shares_display":"1,835","price_per_share":21.27,"price_display":"21.27","price_state":"stated","total_value":39030.45,"total_display":"39,030.45","shares_owned_after":89659.0,"shares_owned_after_display":"89,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-28","filed_date":"2022-07-29","scope":"insider"},{"id":6430496,"accession":"0001209191-22-041628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-041628","line_url":"/filing/0001209191-22-041628#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","shares_owned_after":91494.0,"shares_owned_after_display":"91,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-08","scope":"insider"},{"id":6497007,"accession":"0001209191-22-039654","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-039654","line_url":"/filing/0001209191-22-039654#line-3","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":999.0,"shares_display":"999","price_per_share":20.31,"price_display":"20.31","price_state":"stated","total_value":20289.69,"total_display":"20,289.69","shares_owned_after":91494.0,"shares_owned_after_display":"91,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-28","scope":"insider"},{"id":6497005,"accession":"0001209191-22-039654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-039654","line_url":"/filing/0001209191-22-039654#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","shares_owned_after":92493.0,"shares_owned_after_display":"92,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-28","scope":"insider"},{"id":6455301,"accession":"0001209191-22-026535","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-026535","line_url":"/filing/0001209191-22-026535#line-3","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":24.62,"price_display":"24.62","price_state":"stated","total_value":320060.0,"total_display":"320,060.00","shares_owned_after":92493.0,"shares_owned_after_display":"92,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-02","scope":"insider"},{"id":6455294,"accession":"0001209191-22-026535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-026535","line_url":"/filing/0001209191-22-026535#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1811.0,"shares_display":"1,811","price_per_share":25.57,"price_display":"25.57","price_state":"stated","total_value":46307.27,"total_display":"46,307.27","shares_owned_after":92493.0,"shares_owned_after_display":"92,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6751685,"accession":"0001209191-22-023203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-023203","line_url":"/filing/0001209191-22-023203#line-2","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":30.32,"price_display":"30.32","price_state":"stated","total_value":545760.0,"total_display":"545,760.00","shares_owned_after":94304.0,"shares_owned_after_display":"94,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-01","filed_date":"2022-04-05","scope":"insider"},{"id":6671159,"accession":"0001209191-22-021820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-021820","line_url":"/filing/0001209191-22-021820#line-1","is_derivative":false,"issuer_cik":"0001709772","issuer_name":"Relay Therapeutics, Inc.","issuer_ticker":"RLAY","issuer_name_source":null,"issuer_url":"/issuer/0001709772","owner_cik":"0001709772","owner_name":"Bergstrom Donald A","owner_url":"/insider/0001709772","role":"Officer (President, R&D)","officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":622.0,"shares_display":"622","price_per_share":29.87,"price_display":"29.87","price_state":"stated","total_value":18579.14,"total_display":"18,579.14","shares_owned_after":94304.0,"shares_owned_after_display":"94,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-29","filed_date":"2022-03-31","scope":"insider"}],"next_cursor":"2022-03-29|6671159","ledger_fault":false,"count":{"value":62,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":62,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":62},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001812364","name":"Relay Therapeutics, Inc.","url":"/issuer/0001812364","role":"Officer (President, R&D)","n_filings":52,"first_seen":"2021-04-20","last_seen":"2026-07-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001709772","retrieved_at":"2026-08-21T11:52:18+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}